The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits.
Mark Elliott, MDPsychiatrist in San Francisco, CADr. Elliott has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to these educational activities.
While the age-old tradition of smoking cannabis remains very common, several other options for preparing the drug are becoming widely available and frequently used. In this article, we’ll update you on the modern preparations and routes of administration.
Timmen L. Cermak, MDPrivate practice in psychiatry and addiction psychiatry in San Francisco and Marin County, CA; former president of the California Society of Addiction MedicineDr. Cermak has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to these educational activities.
There is conclusive evidence that marijuana use, particularly in early adolescence, can affect brain development. Most of the effect is on memory, attention, and executive function. How do we prevent these negative effects? Dr. Cermak's advice is: delay, delay, delay. The more success we have getting kids to delay onset of use, the more protection we provide.
Daniel Carlat, MDPublisher, The Carlat Child Psychiatry ReportDr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
While the age-old tradition of smoking cannabis remains very common, several other options for preparing the drug are becoming widely available and frequently used. In this article, we’ll update you on the modern preparations and routes of administration.
Melissa Fluehr
Clinical research coordinator, Behavioral Science Unit, Icahn School of Medicine at Mount Sinai, New York, NY.
Ms. Fluehr has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.Maxwell Luber
Clinical research coordinator, Behavioral Science Unit, Icahn School of Medicine at Mount Sinai, New York, NY.
Mr. Luber has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.Barbara Coffey, MD, MS
Director, National Tourette Center of Excellence, Icahn School of Medicine at Mount Sinai
Dr. Coffey has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Tourette’s disorder (TD), also known as Tourette syndrome, is a fascinating yet complex neurodevelopmental disorder that can be challenging to treat. Dr. Georges Gilles de la Tourette, a French neurologist who described the first nine cases in 1885, had it right when he described the “peculiar” symptoms as a syndrome, later reporting that “fears, phobias, and arithmomania” were part of the picture.
Erica Greenberg, MD
Assistant psychiatrist at Massachusetts General Hospital; Pediatric Neuropsychiatry and Immunology Program within the OCD and Related Disorders Program at Massachusetts General Hospital, Boston, MA
Dr. Greenberg has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Dr. Greenberg works in the obsessive compulsive disorder (OCD) and related disorders program, and I see both kids with tics and OCD or OCD-related disorders as well as those with symptoms consistent with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) or pediatric acute-onset neuropsychiatric syndrome (PANS). She typically sees two to three new patients a week who fit somewhere in the OCD, tic, or PANDAS spectrum.
Glen Elliott, MD, PhD
Editor-in-chief, The Carlat Child Psychiatry Report
In November 2016, the FDA announced that it was requiring two companies to withdraw their generic versions of Concerta (OROS methylphenidate) because of efficacy concerns. Such actions are quite unusual, and when they occur, they tend to shake doctors’ confidence in the generic drug system—which branded drug companies are often eager to encourage. But the Concerta case is hardly an indictment of generic drugs, or even of generic stimulants. Let’s dig a little deeper for some insight into the generic drug process.
Colleen Ryan, MDDr. Ryan has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Study Reviewed: Lenhard F et al. Therapist-guided, Internet-delivered cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: A randomized controlled trial. J Am Acad Child Adolesc Psychiatry 2017;56(1):10–19. doi:10.1016/j.jaac.2016.09.515
Colleen Ryan, MDDr. Ryan has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
We know that kids with ADHD often have sleep issues, and that the stimulants we use to treat them can cause insomnia. What would happen if we focused our treatment on the insomnia portion of ADHD? Presumably kids would sleep better, but would their ADHD symptoms also improve?
The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 2 CME credits.